Beyond the Lab: Clinical Trials
29 April 2025
Shares
Explore how artificial intelligence (AI), biomarkers, and innovative trial technologies are creating a more efficient, data-driven future for drug discovery. From better patient selection to smarter trial design, see how clinical research is evolving to deliver new therapies faster.
In today’s fast-evolving drug discovery landscape, clinical trials face mounting pressures from rising costs and complex protocols to patient recruitment hurdles and logistical challenges in advanced therapies. This exclusive report delivers actionable insights into how the industry is overcoming these barriers through innovation and technology.
What’s inside:
- How biomarkers are unlocking the potential of targeted therapies
- The critical role of IRT in managing complex CGT trial logistics
- Why robust financial planning is now a cornerstone of trial success
- How AI and genomics are reshaping trial design and decision-making
Key challenges this report will address:
- Patient recruitment and retention: Difficulty in finding and enrolling the right patients, especially for niche or stratified populations
- Rising trial costs and delays: Financial mismanagement and inefficient workflows leading to budget overruns and extended timelines
- Complexity of advanced therapies: Managing CGT trials with stringent handling and delivery protocols
- Data fragmentation and siloed systems: Lack of integration between data sources hindering timely decision-making
- Regulatory and compliance pressures: Ensuring data integrity, transparency, and compliance in an evolving regulatory landscape.
Leading industry contributors include:
- Dr Russ Lebovitz – CEO of Amprion
- Cara Woodruff – Director of Product Management at IQVIA IRT
- Jennifer Kyle – Founder and CEO of Condor Software
- Dr Cyril Clarke – Vice President of ICON Biotech
- Dr Remco Jan Geukes Foppen – Consultant at Regina Elena National Cancer Institute
- Vincenzo Gioia – AI Transition Manager – Independent Researcher
- Dr Carlos N Velez – Managing Partner at Lacerta Bio Inc.
- Alessio Zoccoli – Senior Data Scientist – Independent Researcher.
Whether you’re designing your next trial, managing budgets, or navigating the complexities of CGT, this report is your strategic guide to overcoming the toughest obstacles in modern clinical research.
